Animal models of acute myelogenous leukaemia - development, application and future perspectives.
about
Myeloid malignancies: mutations, models and managementAnimal models of leukemia: any closer to the real thing?Cyclic AMP induces IPC leukemia cell apoptosis via CRE-and CDK-dependent Bim transcriptionThe apoptosis-inducing activity towards leukemia and lymphoma cells in a cyanobacterial culture collection is not associated with mouse bioassay toxicityAnti-leukemia activity of a bacterial toxin with natural specificity for LFA-1 on white blood cells.Therapeutic effects of systemic photodynamic therapy in a leukemia animal model using A20 cells.Expression of TP53 isoforms p53β or p53γ enhances chemosensitivity in TP53(null) cell lines.Alkylator-Induced and Patient-Derived Xenograft Mouse Models of Therapy-Related Myeloid Neoplasms Model Clinical Disease and Suggest the Presence of Multiple Cell Subpopulations with Leukemia Stem Cell ActivityGatekeeper pathways and cellular background in the pathogenesis and therapy of AML.Successful engraftment of human acute lymphoblastic leukemia cells in NOD/SCID mice via intrasplenic inoculationCurcumin enhances the cytogenotoxic effect of etoposide in leukemia cells through induction of reactive oxygen speciesXenograft models for the preclinical evaluation of new therapies in acute leukemia.A selective sphingosine kinase 1 inhibitor integrates multiple molecular therapeutic targets in human leukemia.Review: genetic models of acute myeloid leukaemia.CXXC5 (retinoid-inducible nuclear factor, RINF) is a potential therapeutic target in high-risk human acute myeloid leukemiaTherapeutic targeting the cell division cycle 25 (CDC25) phosphatases in human acute myeloid leukemia--the possibility to target several kinases through inhibition of the various CDC25 isoforms.A murine model of acute myeloid leukemia with Evi1 overexpression and autocrine stimulation by an intracellular form of GM-CSF in DA-3 cells.Mouse models for pre-clinical drug testing in leukemia.Multidrug-resistant cancer cells and cancer stem cells hijack cellular systems to circumvent systemic therapies, can natural products reverse this?Cyanobacteria from terrestrial and marine sources contain apoptogens able to overcome chemoresistance in acute myeloid leukemia cells.Biologically active carbazole derivatives: focus on oxazinocarbazoles and related compounds.Synergistic induction of p53 mediated apoptosis by valproic acid and nutlin-3 in acute myeloid leukemia.A rapid and simple assay for human blood malignancy engraftment, homing and chemotherapy treatment using fluorescent imaging of avian embryos.Marine benthic cyanobacteria contain apoptosis-inducing activity synergizing with daunorubicin to kill leukemia cells, but not cardiomyocytes.Lentinan: hematopoietic, immunological, and efficacy studies in a syngeneic model of acute myeloid leukemia.An atlas of bloodstream-accessible bone marrow proteins for site-directed therapy of acute myeloid leukemia.Fludarabine as a cost-effective adjuvant to enhance engraftment of human normal and malignant hematopoiesis in immunodeficient mice.
P2860
Q27000577-07777600-DCC3-4533-9723-56E3DB553E8FQ27026520-E6F3B627-12AA-4F13-816D-2E65D69AB1C9Q28580418-4244CE77-1B29-40F2-897A-4E41D65598F1Q30986837-6BF2EF06-30B7-4ED8-B7BF-AE12F3FA1463Q33808241-419FBCA2-94AC-4262-83FD-D747EC4FBBFAQ33965060-E2C24631-BB0F-4797-8814-AC1FD0614A56Q34586799-042EADE6-C540-4698-91EB-FE6BFF818DF2Q36080036-A428A141-1680-4CE1-80BD-59F76EC60B69Q36233848-FE5F98A6-A2E1-490C-8BC1-81ADBF8E875AQ36312138-63BD972F-FBA6-44F5-8D93-D5562AE8FABBQ36557734-73C1F184-E69B-426C-8907-5329CE62B2BBQ36799846-0680AFD0-E5DA-4AD7-8B5E-536DAE0CBFF7Q36835151-C8A7667E-D32D-4205-82F9-7FF417963873Q37080843-ABAEEFFE-481A-425E-921D-8E4A8CF25A1CQ37299309-9AAAC68D-7995-4300-8275-AC2E8A487E1BQ38268221-4F3D2205-6355-4001-8E76-B7E2BE3CE041Q38882990-7F7DCFF2-9862-4C44-BE26-5BC7FE6FA55CQ38937610-B7B93DFE-4143-4DED-9B2E-6209B1C86D1FQ38953085-CA153C94-83A4-44B5-9736-9743E78063D2Q39007306-6C4E02AF-10BB-49E6-B2B9-A6FCAD95B69BQ39008583-EB95F33F-DD91-475A-B8FC-D50567010E73Q39446764-5D3B4621-084B-44CB-AED8-930939D91B5EQ39479064-9B6D224F-BBEB-4973-89EB-7B5C1E138246Q39626111-A2292950-08B7-4087-998B-6F32B7A7EE54Q43006946-8AABAA72-018B-4A09-9E51-25C88EE26882Q45869295-49508066-BBC7-494D-A883-5E3557854F2BQ55302532-055F227D-1419-43A7-8385-E168048FD2DD
P2860
Animal models of acute myelogenous leukaemia - development, application and future perspectives.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Animal models of acute myeloge ...... ation and future perspectives.
@ast
Animal models of acute myeloge ...... ation and future perspectives.
@en
type
label
Animal models of acute myeloge ...... ation and future perspectives.
@ast
Animal models of acute myeloge ...... ation and future perspectives.
@en
prefLabel
Animal models of acute myeloge ...... ation and future perspectives.
@ast
Animal models of acute myeloge ...... ation and future perspectives.
@en
P2860
P356
P1433
P1476
Animal models of acute myeloge ...... cation and future perspectives
@en
P2093
Bruserud O
P2860
P2888
P304
P356
10.1038/SJ.LEU.2403670
P577
2005-05-01T00:00:00Z